Literature DB >> 19208840

Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy.

Stefano Indraccolo1, Sonia Minuzzo, Massimo Masiero, Irene Pusceddu, Luca Persano, Lidia Moserle, Andrea Reboldi, Elena Favaro, Marco Mecarozzi, Giuseppina Di Mario, Isabella Screpanti, Maurilio Ponzoni, Claudio Doglioni, Alberto Amadori.   

Abstract

The Notch ligand Dll4 has a recognized role during both physiologic and tumor angiogenesis, as it contributes to regulate Notch activity in endothelial cells (EC). The effects of Dll4 on Notch signaling in tumor cells expressing Notch receptors remain, however, largely unknown. Here, we report that escape of human T-cell acute lymphoblastic leukemia (T-ALL) cells or colorectal cancer cells from dormancy is associated with Dll4 expression in the tumor microenvironment and increased Notch3 signaling in tumor cells. Dll4 was expressed at early time points during the angiogenic process, and its expression preceded perfusion of the newly established vessels. Treatment of EC with angiogenic factors induced Dll4 expression and increased Notch3 activation in cocultured T-ALL cells. Neutralization of Dll4 greatly reduced EC-mediated activation of Notch 3 signaling in T-ALL cells and blocked tumorigenesis. Moreover, silencing Notch3 by RNA interference had marked antiproliferative and proapoptotic effects on T-ALL cells in vitro and reduced tumorigenicity in vivo. Our results elucidate a novel mechanism by which a direct interplay between endothelial and tumor cells promotes survival and triggers tumor growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208840     DOI: 10.1158/0008-5472.CAN-08-2791

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Cancer stem cells: nature versus nurture.

Authors:  Hasan Korkaya; Max S Wicha
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

Review 2.  The Role of Notch3 in Cancer.

Authors:  Zviadi Aburjania; Samuel Jang; Jason Whitt; Renata Jaskula-Stzul; Herbert Chen; J Bart Rose
Journal:  Oncologist       Date:  2018-04-05

Review 3.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

Review 4.  Mechanisms of disseminated cancer cell dormancy: an awakening field.

Authors:  María Soledad Sosa; Paloma Bragado; Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2014-08-14       Impact factor: 60.716

5.  Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells.

Authors:  Liliana Mendonça; Alexandre Trindade; Catarina Carvalho; Jorge Correia; Marina Badenes; Joana Gigante; António Duarte
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

6.  Expression and clinical significance of Notch signaling genes in colorectal cancer.

Authors:  Hei-Ying Jin; Hong-Ying Zhang; Xiaofeng Wang; Junhua Xu; Yijing Ding
Journal:  Tumour Biol       Date:  2012-01-05

7.  CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.

Authors:  L M Sarmento; V Póvoa; R Nascimento; G Real; I Antunes; L R Martins; C Moita; P M Alves; M Abecasis; L F Moita; R M E Parkhouse; J P P Meijerink; J T Barata
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

8.  The Instructive Role of the Vasculature in Stem Cell Niches.

Authors:  Andrew J Putnam
Journal:  Biomater Sci       Date:  2014-11       Impact factor: 6.843

Review 9.  Dormancy in solid tumors: implications for prostate cancer.

Authors:  Nazanin S Ruppender; Colm Morrissey; Paul H Lange; Robert L Vessella
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

10.  Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.

Authors:  A M Jubb; H Turley; H C Moeller; G Steers; C Han; J-L Li; R Leek; E Y Tan; B Singh; N J Mortensen; I Noguera-Troise; F Pezzella; K C Gatter; G Thurston; S B Fox; A L Harris
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.